Zharko Daniloski
- Molecular Biology top 10%
- Infectious Diseases top 5%
- Immunology
- Genetics
- Oncology
- Co-authors
- Neville E. SanjanaMateusz LegutHans‐Hermann WesselsBenjamin R. tenOeverTristan X. JordanAlejandro Méndez‐MancillaLu LuEleni P. Mimitou
- Topics
- CRISPR and Genetic Engineering (8 papers)SARS-CoV-2 and COVID-19 Research (3 papers)Single-cell and spatial transcriptomics (3 papers)
- Partner nations
- United StatesSwedenGermany
In The Last Decade
Zharko Daniloski
12 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Molecular Biology 721
- Infectious Diseases 402
- Immunology 137
- Genetics 132
- Oncology 120
Countries citing papers authored by Zharko Daniloski
This map shows the geographic impact of Zharko Daniloski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zharko Daniloski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zharko Daniloski more than expected).
Fields of papers citing papers by Zharko Daniloski
This network shows the impact of papers produced by Zharko Daniloski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zharko Daniloski. The network helps show where Zharko Daniloski may publish in the future.
Co-authorship network of co-authors of Zharko Daniloski
This figure shows the co-authorship network connecting the top 25 collaborators of Zharko Daniloski. A scholar is included among the top collaborators of Zharko Daniloski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zharko Daniloski. Zharko Daniloski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 84 | |
| 2 | 111 | |
| 3 | 11 | |
| 4 | 17 | |
| 5 | 149 | |
| 6 | 30 | |
| 7 | Massively parallel Cas13 screens reveal principles for guide RNA designbreakdown → | 272 |
| 8 | 348 | |
| 9 | 41 | |
| 10 | 21 | |
| 11 | 25 | |
| 12 | 34 |
About Zharko Daniloski
Zharko Daniloski is a scholar working on Aging, Infectious Diseases and Molecular Biology, having authored 12 papers that have together received 1.1k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (8 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Single-cell and spatial transcriptomics (3 papers). The work is most often cited by research in Infectious Diseases (402 citations), Aging (21 citations) and Business and International Management (22 citations). Zharko Daniloski has collaborated with scholars based in United States, Sweden and Germany. Frequent co-authors include Neville E. Sanjana, Mateusz Legut, Hans‐Hermann Wessels, Benjamin R. tenOever, Tristan X. Jordan, Alejandro Méndez‐Mancilla, Lu Lu, Eleni P. Mimitou, Peter Smibert and Tuuli Lappalainen. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.